BlackRock’s Rain Oncology Inc. Common Stock RAIN Stock Holding History

BlackRock’s Portfolio RAIN Stock Details RAIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,090,707	Closed	-$1.31M	–	5473
2023 Q4	$1.31M	Buy	1,090,707 +75,322	+7%	+$81.3K	﹤0.01%	4176
2023 Q3	$875K	Sell	1,015,385 -1,145	-0.1%	-$1.25K	﹤0.01%	4281
2023 Q2	$1.22M	Buy	1,016,530 +941,037	+1,247%	+$4.71M	﹤0.01%	4234
2023 Q1	$660K	Buy	75,493 +26,099	+53%	+$241K	﹤0.01%	4464
2022 Q4	$395K	Sell	49,394 -88,549	-64%	-$556K	﹤0.01%	4673
2022 Q3	$673K	Sell	137,943 -4,052	-3%	-$25.4K	﹤0.01%	4627
2022 Q2	$790K	Sell	141,995 -661,216	-82%	-$2.27M	﹤0.01%	4628
2022 Q1	$4.07M	Buy	803,211 +62,340	+8%	+$500K	﹤0.01%	4076
2021 Q4	$9.54M	Buy	740,871 +368,124	+99%	+$5.26M	﹤0.01%	3702
2021 Q3	$5.58M	Buy	372,747 +15,159	+4%	+$259K	﹤0.01%	3917
2021 Q2	$5.56M	Buy	+357,588	New	+$6.27M	﹤0.01%	3842

BlackRock's RAIN Position: Q1 2024 in Review

BlackRock sold out of Rain Oncology Inc. Common Stock (RAIN) in Q1 2024, closing a stake of 1,090,707 shares — an estimated $1.31M sold.

BlackRock first reported a position in RAIN in Q2 2021 and held it in 11 quarters. The position peaked at $9.54M in Q4 2021. 0 funds tracked by Wall St. Rank hold RAIN as of Q1 2024.

BlackRock reported no remaining Rain Oncology Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
BlackRock sold 1,090,707 Rain Oncology Inc. Common Stock shares in Q1 2024, an estimated $1.31M.
BlackRock first reported a position in Rain Oncology Inc. Common Stock in Q2 2021 and held it in 11 quarters.
BlackRock's Rain Oncology Inc. Common Stock position peaked at $9.54M in Q4 2021.
0 funds tracked by Wall St. Rank held Rain Oncology Inc. Common Stock as of Q1 2024.

Based on BlackRock's 13F filing for Q1 2024, filed 10 May 2024.